Print

VIVUS, Inc. (VVUS) Collaborates With Aetna To Test First Comprehensive Weight Management Program Integrating Weight Loss Medication  
1/14/2014 9:14:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., Jan. 14, 2014 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS), today announced that it has joined with Aetna (NYSE:AET), one of the nation's leading diversified health care benefits companies, to integrate Qsymia® (phentermine and topiramate extended-release) capsules CIV into a pilot program designed to evaluate the benefits of prescription medication combined with lifestyle support for weight loss. The program is the first of its kind involving Qsymia and a health care benefits provider.

Help employers find you! Check out all the jobs and post your resume.

//-->